Therapeutics: OX40 ligand (OX40L; CD134L)

Autoimmune disease

INDICATION: Scleroderma

Patient sample and mouse studies suggest inhibiting OX40L could help treat systemic sclerosis. In patient skin and serum samples,

Read the full 219 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE